Cystic fibrosis is a non-curable genetic disease that affects mucus production and clearance in the lungs, pancreas, and other organs. Respiratory therapists interact with patients with cystic fibrosis throughout the stages of the disease: diagnosis in early childhood and disease progression through adulthood. It is important for respiratory therapists to not only understand the underlying physiology of the disease and how it is diagnosed but also what available treatment interventions should be used at any given phase of the disease process. The respiratory therapist can contribute to the multidisciplinary care plan of the patient with cystic fibrosis to promote the best lung health as well as quality of life. This presentation will detail the pathophysiology of cystic fibrosis as well as the various diagnostic tools and current treatment strategies.

Presented by Dabney Eidson, BS, RRT, RRT-NPS

This Live AARC webcast is approved for 1.0 CRCE

This activity has been funded through educational grants from Chiesi and Vertex Pharmaceuticals.

Seminar Objectives
  • Identify key features of the pathophysiology of cystic fibrosis, including physical assessment findings
  • Discuss the various diagnostic tools available for assessing progression of cystic fibrosis lung disease
  • Relate available intervention strategies for cystic fibrosis as applicable to the patientís condition and co-morbidities
Seminar Information
Date Presented:
May 29, 2018 2:00 PM Eastern
Expiration Date:
May 29, 2018 11:55 PM
1 hour
Life/Honorary Price:
Member Price:
Senior Active Price:
Senior Associate Price:
Student Price:
WEB Sign-up Price:
Full Price:
The Role of the Respiratory Therapist in Cystic Fibrosis
Individual topic purchase: Selected
American Association for Respiratory Care
Continuing Respiratory Care Education: 1.00